| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 149, Issue 9 2879-2886, Copyright © 1992 by American Association of Immunologists
ARTICLES |
T Imai, K Fukudome, S Takagi, M Nagira, M Furuse, N Fukuhara, M Nishimura, Y Hinuma and O Yoshie
Shionogi Institute for Medical Science, Osaka, Japan.
C33 Ag was originally identified by mAb inhibitory to syncytium formation induced by human T cell leukemia virus type 1. The Ag was shown to be a highly heterogeneous glycoprotein consisting of a 28-kDa protein and N-linked oligosaccharides ranging from 10 to 50 kDa. In the present study, cDNA clones were isolated from a human T cell cDNA expression library in Escherichia coli by using mAb C33. The identity of cDNA was verified by immunostaining and immunoprecipitation of transfected NIH3T3 cells with mAb. The cDNA contained an open reading frame of a 267-amino acid sequence which was a type III integral membrane protein of 29.6 kDa with four putative transmembrane domains and three putative N-glycosylation sites. The C33 gene was found to belong to a newly defined family of genes for membrane proteins, such as CD9, CD37, CD53, CD63, and TAPA-1, and was identical to R2, a cDNA recently isolated because of its strong up-regulation after T cell activation. Availability of mAb for C33 Ag enabled us to define its distribution in human leukocytes. C33 Ag was expressed in CD4+ T cells, CD19+ B cells, CD14+ monocytes, and CD16+ granulocytes. Its expression was low in CD8+ T cells and mostly negative in CD16+ NK cells. PHA stimulation enhanced the expression of C33 Ag in CD4+ T cells by about 5-fold and in CD8+ T cells by about 20-fold. PHA stimulation also induced the dramatic size changes in the N-linked sugars previously shown to accompany human T cell leukemia virus type 1-induced transformation of CD4+ T cells.
This article has been cited by other articles:
|
|
 |
|
  J. M. Taylor, M. Brown, M. Nejmeddine, K. J. Kim, L. Ratner, M. Lairmore, and C. Nicot Novel Role for Interleukin-2 Receptor-Jak Signaling in Retrovirus Transmission J. Virol., November 15, 2009; 83(22): 11467 - 11476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Bari, Y. H. Zhang, F. Zhang, N. X. Wang, C. S. Stipp, J. J. Zheng, and X. A. Zhang Transmembrane Interactions Are Needed for KAI1/CD82-Mediated Suppression of Cancer Invasion and Metastasis Am. J. Pathol., February 1, 2009; 174(2): 647 - 660. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Takeda, N. Hattori, T. Tokuhara, Y. Nishimura, M. Yokoyama, and M. Miyake Adenoviral Transduction of MRP-1/CD9 and KAI1/CD82 Inhibits Lymph Node Metastasis in Orthotopic Lung Cancer Model Cancer Res., February 15, 2007; 67(4): 1744 - 1749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Ho, F. Martin, A. Higginbottom, L. J. Partridge, V. Parthasarathy, G. W. Moseley, P. Lopez, C. Cheng-Mayer, and P. N. Monk Recombinant extracellular domains of tetraspanin proteins are potent inhibitors of the infection of macrophages by human immunodeficiency virus type 1. J. Virol., July 1, 2006; 80(13): 6487 - 6496. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Singethan, E. Topfstedt, S. Schubert, W. P. Duprex, B. K. Rima, and J. Schneider-Schaulies CD9-dependent regulation of Canine distemper virus-induced cell-cell fusion segregates with the extracellular domain of the haemagglutinin J. Gen. Virol., June 1, 2006; 87(6): 1635 - 1642. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Martin, D. M. Roth, D. A. Jans, C. W. Pouton, L. J. Partridge, P. N. Monk, and G. W. Moseley Tetraspanins in Viral Infections: a Fundamental Role in Viral Biology? J. Virol., September 1, 2005; 79(17): 10839 - 10851. [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Clark, A. Oelke, M. E. Johnson, K. D. Eilert, P. C. Simpson, and S. C. Todd CD81 Associates with 14-3-3 in a Redox-regulated Palmitoylation-dependent Manner J. Biol. Chem., May 7, 2004; 279(19): 19401 - 19406. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S AmirthaLakshmi, V Pushparaj, V Krishnamurthy, J Biswas, S Krishnakumar, and M P Shanmugam Tetraspanin protein KAI1 expression in retinoblastoma Br J Ophthalmol, April 1, 2004; 88(4): 593 - 595. [Full Text] [PDF]
|
|
|
|
|
|
J. D. Pinon, P. J. Klasse, S. R. Jassal, S. Welson, J. Weber, D. W. Brighty, and Q. J. Sattentau Human T-Cell Leukemia Virus Type 1 Envelope Glycoprotein gp46 Interacts with Cell Surface Heparan Sulfate Proteoglycans J. Virol., September 15, 2003; 77(18): 9922 - 9930. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. A. Zhang, W. S. Lane, S. Charrin, E. Rubinstein, and L. Liu EWI2/PGRL Associates with the Metastasis Suppressor KAI1/CD82 and Inhibits the Migration of Prostate Cancer Cells Cancer Res., May 15, 2003; 63(10): 2665 - 2674. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. von Lindern, D. Rojo, K. Grovit-Ferbas, C. Yeramian, C. Deng, G. Herbein, M. R. Ferguson, T. C. Pappas, J. M. Decker, A. Singh, et al. Potential Role for CD63 in CCR5-Mediated Human Immunodeficiency Virus Type 1 Infection of Macrophages J. Virol., March 15, 2003; 77(6): 3624 - 3633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-S. Gatot, I. Callebaut, C. Van Lint, D. Demonte, P. Kerkhofs, D. Portetelle, A. Burny, L. Willems, and R. Kettmann Bovine Leukemia Virus SU Protein Interacts with Zinc, and Mutations within Two Interacting Regions Differently Affect Viral Fusion and Infectivity In Vivo J. Virol., July 17, 2002; 76(16): 7956 - 7967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Uzawa, K. Ono, H. Suzuki, C. Tanaka, T. Yakushiji, N. Yamamoto, H. Yokoe, and H. Tanzawa High Prevalence of Decreased Expression of KAI1 Metastasis Suppressor in Human Oral Carcinogenesis Clin. Cancer Res., March 1, 2002; 8(3): 828 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Seigneuret, A. Delaguillaumie, C. Lagaudriere-Gesbert, and H. Conjeaud Structure of the Tetraspanin Main Extracellular Domain. A PARTIALLY CONSERVED FOLD WITH A STRUCTURALLY VARIABLE DOMAIN INSERTION J. Biol. Chem., October 19, 2001; 276(43): 40055 - 40064. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. R. Jassal, R. G. Pohler, and D. W. Brighty Human T-Cell Leukemia Virus Type 1 Receptor Expression among Syncytium-Resistant Cell Lines Revealed by a Novel Surface Glycoprotein-Immunoadhesin J. Virol., September 1, 2001; 75(17): 8317 - 8328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, L. L. Wei, C. Tang, R. Slack, S. Mueller, and M. E. Lippman Overexpression of KAI1 Suppresses in Vitro Invasiveness and in Vivo Metastasis in Breast Cancer Cells Cancer Res., July 1, 2001; 61(13): 5284 - 5288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Clay, E. Rubinstein, Z. Mishal, A. Anjo, M. Prenant, C. Jasmin, C. Boucheix, and M.-C. L. Bousse-Kerdiles CD9 and megakaryocyte differentiation Blood, April 1, 2001; 97(7): 1982 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Yang, L. Wei, C. Tang, R. Slack, E. Montgomery, and M. Lippman KAI1 Protein Is Down-Regulated during the Progression of Human Breast Cancer Clin. Cancer Res., September 1, 2000; 6(9): 3424 - 3429. [Abstract] [Full Text]
|
|
|
|
|
|
E. Schmid, A. Zurbriggen, U. Gassen, B. Rima, V. ter Meulen, and J. Schneider-Schaulies Antibodies to CD9, a Tetraspan Transmembrane Protein, Inhibit Canine Distemper Virus-Induced Cell-Cell Fusion but Not Virus-Cell Fusion J. Virol., August 15, 2000; 74(16): 7554 - 7561. [Abstract] [Full Text]
|
|
|
|
 |
|
 S Daenke and S Booth HTLV-1-induced cell fusion is limited at two distinct steps in the fusion pathway after receptor binding J. Cell Sci., January 1, 2000; 113(1): 37 - 44. [Abstract] [PDF]
|
|
|
|
|
|
M. A. Sommerfelt Retrovirus receptors J. Gen. Virol., December 1, 1999; 80(12): 3049 - 3064. [Full Text]
|
|
|
|
|
|
D. P. Lombardi, J. Geradts, J. F. Foley, C. Chiao, P. W. Lamb, and J. C. Barrett Loss of KAI1 Expression in the Progression of Colorectal Cancer Cancer Res., November 1, 1999; 59(22): 5724 - 5731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Tachibana and M. E. Hemler Role of Transmembrane 4 Superfamily (Tm4sf) Proteins Cd9 and Cd81 in Muscle Cell Fusion and Myotube Maintenance J. Cell Biol., August 23, 1999; 146(4): 893 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Geradts, R. Maynard, M. J. Birrer, D. Hendricks, S. L. Abbondanzo, K. M. Fong, J. C. Barrett, and D. P. Lombardi Frequent Loss of KAI1 Expression in Squamous and Lymphoid Neoplasms : An Immunohistochemical Study of Archival Tissues Am. J. Pathol., June 1, 1999; 154(6): 1665 - 1671. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. K. Hildreth Syncytium-Inhibiting Monoclonal Antibodies Produced against Human T-Cell Lymphotropic Virus Type 1-Infected Cells Recognize Class II Major Histocompatibility Complex Molecules and Block by Protein Crowding J. Virol., December 1, 1998; 72(12): 9544 - 9552. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Hammond, L. K. Denzin, M. Pan, J. M. Griffith, H. J. Geuze, and P. Cresswell The Tetraspan Protein CD82 Is a Resident of MHC Class II Compartments Where It Associates with HLA-DR, -DM, and -DO Molecules J. Immunol., October 1, 1998; 161(7): 3282 - 3291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-l. Huang, N. Kohno, E. Ogawa, M. Adachi, T. Taki, and M. Miyake Correlation of Reduction in MRP-1/CD9 and KAI1/CD82 Expression with Recurrences in Breast Cancer Patients Am. J. Pathol., September 1, 1998; 153(3): 973 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-M. Escola, M. J. Kleijmeer, W. Stoorvogel, J. M. Griffith, O. Yoshie, and H. J. Geuze Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes J. Biol. Chem., August 7, 1998; 273(32): 20121 - 20127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. M. Wice and J. I. Gordon A Tetraspan Membrane Glycoprotein Produced in the Human Intestinal Epithelium and Liver That Can Regulate Cell Density-dependent Proliferation J. Biol. Chem., September 15, 1995; 270(37): 21907 - 21918. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Dong, P. Lamb, C. Rinker-Schaeffer, J Vukanovic, T Ichikawa, J. Isaacs, and J. Barrett KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2 Science, May 12, 1995; 268(5212): 884 - 886. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
